Nan Fung Group Holdings as of Sept. 30, 2022
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 39 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 34.7 | $54M | 242k | 224.93 | |
| Illumina (ILMN) | 14.5 | $23M | 119k | 190.79 | |
| Harmony Biosciences Hldgs In (HRMY) | 14.4 | $23M | 511k | 44.29 | |
| Exscientia Ads (EXAI) | 4.5 | $7.0M | 853k | 8.21 | |
| Seagen | 4.1 | $6.4M | 47k | 136.83 | |
| Somalogic Class A Com | 3.1 | $4.9M | 1.7M | 2.90 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 3.0 | $4.7M | 494k | 9.58 | |
| Xenon Pharmaceuticals (XENE) | 2.6 | $4.1M | 114k | 36.10 | |
| Eargo | 1.9 | $3.0M | 2.9M | 1.05 | |
| Replimune Group (REPL) | 1.7 | $2.7M | 155k | 17.27 | |
| Incyte Corporation (INCY) | 1.5 | $2.3M | 34k | 66.65 | |
| Chinook Therapeutics | 1.4 | $2.2M | 114k | 19.66 | |
| Entrada Therapeutics (TRDA) | 1.4 | $2.2M | 142k | 15.76 | |
| Iveric Bio | 1.3 | $2.0M | 112k | 17.94 | |
| Chemocentryx | 1.2 | $1.9M | 36k | 51.66 | |
| Bolt Biotherapeutics (BOLT) | 1.1 | $1.7M | 1.2M | 1.48 | |
| Beigene Sponsored Adr | 1.0 | $1.6M | 12k | 134.84 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $1.1M | 79k | 14.51 | |
| Satsuma Pharmaceuticals Ord | 0.7 | $1.1M | 178k | 6.00 | |
| Galera Therapeutics (GRTX) | 0.7 | $1.1M | 613k | 1.74 | |
| Exelixis (EXEL) | 0.6 | $1.0M | 64k | 15.69 | |
| Pacific Biosciences of California (PACB) | 0.5 | $841k | 145k | 5.81 | |
| Dbv Technologies S A Sponsored Adr | 0.4 | $657k | 371k | 1.77 | |
| 2seventy Bio Common Stock (TSVT) | 0.4 | $586k | 40k | 14.55 | |
| BioMarin Pharmaceutical (BMRN) | 0.3 | $518k | 6.1k | 84.71 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $491k | 30k | 16.38 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $430k | 4.2k | 103.17 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $401k | 42k | 9.56 | |
| Argenx Se Sponsored Adr (ARGX) | 0.3 | $392k | 1.1k | 353.15 | |
| Otonomy | 0.2 | $251k | 851k | 0.29 | |
| Relmada Therapeutics (RLMD) | 0.1 | $209k | 5.6k | 37.04 | |
| Reata Pharmaceuticals Cl A | 0.1 | $208k | 8.3k | 25.17 | |
| Fibrogen (FGEN) | 0.1 | $192k | 15k | 13.01 | |
| Affimed Therapeutics B V | 0.1 | $167k | 81k | 2.06 | |
| Kodiak Sciences (KOD) | 0.1 | $152k | 20k | 7.75 | |
| Abcellera Biologics (ABCL) | 0.1 | $124k | 13k | 9.90 | |
| Synlogic | 0.0 | $65k | 69k | 0.95 | |
| Cerus Corporation (CERS) | 0.0 | $51k | 14k | 3.60 | |
| Invitae (NVTAQ) | 0.0 | $28k | 11k | 2.47 |
